Xenon Pharmaceuticals said on Monday that its experimental drug to treat moderate to severe major depressive disorder (MDD) had failed to significantly reduce the severity of depressive episodes compared to a placebo, in a mid-stage study.
https://finance.yahoo.com/news/1-canadas-xenon-pharmas-depression-123034333.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.